Antibiotic Resistance Market Report by Disease (CUTI (Complicated Urinary Tract Infections), CDI (Clostridioides Difficile Infection), ABSSSI (Acute Bacterial Skin and Skin Structure Infections), HABP (Hospital-Acquired Bacterial Pneumonia), CABP (Community-Acquired Pneumonia), CIAI (Complicated Intra-Abdominal Infection), BSI (Bloodstream Infection)), Pathogen (E. Coli, K. Pneumoniae, P. Aeruginosa, S. Aureus, A. Baumannii, S. Pneumoniae, H. Influenzae, C. Difficile, E. Faecium), Drug Class (Oxazolidinones, Lipoglycopeptides, Tetracyclines, Combination Therapies, Cephalosporins, and Others), Mechanism of Action (Protein Synthesis Inhibitors, Cell Wall Synthesis Inhibitors, RNA Synthesis Inhibitors, DNA Synthesis Inhibitors, and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and Region 2023-2028

Antibiotic Resistance Market Report by Disease (CUTI (Complicated Urinary Tract Infections), CDI (Clostridioides Difficile Infection), ABSSSI (Acute Bacterial Skin and Skin Structure Infections), HABP (Hospital-Acquired Bacterial Pneumonia), CABP (Community-Acquired Pneumonia), CIAI (Complicated Intra-Abdominal Infection), BSI (Bloodstream Infection)), Pathogen (E. Coli, K. Pneumoniae, P. Aeruginosa, S. Aureus, A. Baumannii, S. Pneumoniae, H. Influenzae, C. Difficile, E. Faecium), Drug Class (Oxazolidinones, Lipoglycopeptides, Tetracyclines, Combination Therapies, Cephalosporins, and Others), Mechanism of Action (Protein Synthesis Inhibitors, Cell Wall Synthesis Inhibitors, RNA Synthesis Inhibitors, DNA Synthesis Inhibitors, and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and Region 2023-2028

Report Format: PDF+Excel | Report ID: SR112024A9851
Buy Now

1 Preface

2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Deployments
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology

3 Executive Summary

4 Global Antibiotic Resistance Market - Introduction
4.1 Overview
4.2 Market Dynamics
4.3 Industry Trends
4.4 Competitive Intelligence

5 Global Antibiotic Resistance Market Landscape
5.1 Historical and Current Market Trends (2017-2022)
5.2 Market Forecast (2023-2028)

6 Global Antibiotic Resistance Market - Breakup by Disease
6.1 CUTI (Complicated Urinary Tract Infections)

6.1.1 Overview
6.1.2 Historical and Current Market Trends (2017-2022)
6.1.3 Market Segmentation
6.1.4 Market Forecast (2023-2028)
6.2 CDI (Clostridioides Difficile Infection)
6.2.1 Overview
6.2.2 Historical and Current Market Trends (2017-2022)
6.2.3 Market Segmentation
6.2.4 Market Forecast (2023-2028)
6.3 ABSSSI (Acute Bacterial Skin and Skin Structure Infections)
6.3.1 Overview
6.3.2 Historical and Current Market Trends (2017-2022)
6.3.3 Market Segmentation
6.3.4 Market Forecast (2023-2028)
6.4 HABP (Hospital-Acquired Bacterial Pneumonia)
6.4.1 Overview
6.4.2 Historical and Current Market Trends (2017-2022)
6.4.3 Market Segmentation
6.4.4 Market Forecast (2023-2028)
6.5 CABP (Community-Acquired Pneumonia)
6.5.1 Overview
6.5.2 Historical and Current Market Trends (2017-2022)
6.5.3 Market Segmentation
6.5.4 Market Forecast (2023-2028)
6.6 CIAI (Complicated Intra-Abdominal Infection)
6.6.1 Overview
6.6.2 Historical and Current Market Trends (2017-2022)
6.6.3 Market Segmentation
6.6.4 Market Forecast (2023-2028)
6.7 BSI (Bloodstream Infection)
6.7.1 Overview
6.7.2 Historical and Current Market Trends (2017-2022)
6.7.3 Market Segmentation
6.7.4 Market Forecast (2023-2028)
6.8 Attractive Investment Proposition by Disease

7 Global Antibiotic Resistance Market - Breakup by Pathogen
7.1 E. Coli

7.1.1 Overview
7.1.2 Historical and Current Market Trends (2017-2022)
7.1.3 Market Segmentation
7.1.4 Market Forecast (2023-2028)
7.2 K. Pneumoniae
7.2.1 Overview
7.2.2 Historical and Current Market Trends (2017-2022)
7.2.3 Market Segmentation
7.2.4 Market Forecast (2023-2028)
7.3 P. Aeruginosa
7.3.1 Overview
7.3.2 Historical and Current Market Trends (2017-2022)
7.3.3 Market Segmentation
7.3.4 Market Forecast (2023-2028)
7.4 S. Aureus
7.4.1 Overview
7.4.2 Historical and Current Market Trends (2017-2022)
7.4.3 Market Segmentation
7.4.4 Market Forecast (2023-2028)
7.5 A. Baumannii
7.5.1 Overview
7.5.2 Historical and Current Market Trends (2017-2022)
7.5.3 Market Segmentation
7.5.4 Market Forecast (2023-2028)
7.6 S. Pneumoniae
7.6.1 Overview
7.6.2 Historical and Current Market Trends (2017-2022)
7.6.3 Market Segmentation
7.6.4 Market Forecast (2023-2028)
7.7 H. Influenzae
7.7.1 Overview
7.7.2 Historical and Current Market Trends (2017-2022)
7.7.3 Market Segmentation
7.7.4 Market Forecast (2023-2028)
7.8 C. Difficile
7.8.1 Overview
7.8.2 Historical and Current Market Trends (2017-2022)
7.8.3 Market Segmentation
7.8.4 Market Forecast (2023-2028)
7.9 E. Faecium
7.9.1 Overview
7.9.2 Historical and Current Market Trends (2017-2022)
7.9.3 Market Segmentation
7.9.4 Market Forecast (2023-2028)
7.10 Attractive Investment Proposition by Pathogen

8 Global Antibiotic Resistance Market - Breakup by Drug Class
8.1 Oxazolidinones

8.1.1 Overview
8.1.2 Historical and Current Market Trends (2017-2022)
8.1.3 Market Segmentation
8.1.4 Market Forecast (2023-2028) 
8.2 Lipoglycopeptides
8.2.1 Overview
8.2.2 Historical and Current Market Trends (2017-2022)
8.2.3 Market Segmentation
8.2.4 Market Forecast (2023-2028)
8.3 Tetracyclines
8.3.1 Overview
8.3.2 Historical and Current Market Trends (2017-2022)
8.3.3 Market Segmentation
8.3.4 Market Forecast (2023-2028) 
8.4 Combination Therapies
8.4.1 Overview
8.4.2 Historical and Current Market Trends (2017-2022)
8.4.3 Market Segmentation
8.4.4 Market Forecast (2023-2028)
8.5 Cephalosporins
8.5.1 Overview
8.5.2 Historical and Current Market Trends (2017-2022)
8.5.3 Market Segmentation
8.5.4 Market Forecast (2023-2028) 
8.6 Others
8.6.1 Historical and Current Market Trends (2017-2022)
8.6.2 Market Forecast (2023-2028)
8.7 Attractive Investment Proposition by Drug Class

9 Global Antibiotic Resistance Market - Breakup by Mechanism of Action
9.1 Protein Synthesis Inhibitors

9.1.1 Overview
9.1.2 Historical and Current Market Trends (2017-2022)
9.1.3 Market Segmentation
9.1.4 Market Forecast (2023-2028)
9.2 Cell Wall Synthesis Inhibitors
9.2.1 Overview
9.2.2 Historical and Current Market Trends (2017-2022)
9.2.3 Market Segmentation
9.2.4 Market Forecast (2023-2028)
9.3 RNA Synthesis Inhibitors
9.3.1 Overview
9.3.2 Historical and Current Market Trends (2017-2022)
9.3.3 Market Segmentation
9.3.4 Market Forecast (2023-2028)
9.4 DNA Synthesis Inhibitors
9.4.1 Overview
9.4.2 Historical and Current Market Trends (2017-2022)
9.4.3 Market Segmentation
9.4.4 Market Forecast (2023-2028)
9.5 Others
9.5.1 Historical and Current Market Trends (2017-2022)
9.5.2 Market Forecast (2023-2028)
9.6 Attractive Investment Proposition by Mechanism of Action

10 Global Antibiotic Resistance Market - Breakup by Distribution Channel
10.1 Hospital Pharmacies

10.1.1 Overview
10.1.2 Historical and Current Market Trends (2017-2022)
10.1.3 Market Segmentation
10.1.4 Market Forecast (2023-2028)
10.2 Retail Pharmacies
10.2.1 Overview
10.2.2 Historical and Current Market Trends (2017-2022)
10.2.3 Market Segmentation
10.2.4 Market Forecast (2023-2028)
10.3 Online Pharmacies
10.3.1 Overview
10.3.2 Historical and Current Market Trends (2017-2022)
10.3.3 Market Segmentation
10.3.4 Market Forecast (2023-2028)
10.4 Attractive Investment Proposition by Distribution Channel

11 Global Antibiotic Resistance Market – Breakup by Region
11.1 North America
11.1.1 United States

11.1.1.1 Market Drivers
11.1.1.2 Historical and Current Market Trends (2017-2022)
11.1.1.3 Market Breakup by Disease
11.1.1.4 Market Breakup by Pathogen
11.1.1.5 Market Breakup by Drug Class
11.1.1.6 Market Breakup by Mechanism of Action
11.1.1.7 Market Breakup by Distribution Channel
11.1.1.8 Key Players
11.1.1.9 Market Forecast (2023-2028)
11.1.2 Canada
11.1.2.1 Market Drivers
11.1.2.2 Historical and Current Market Trends (2017-2022)
11.1.2.3 Market Breakup by Disease
11.1.2.4 Market Breakup by Pathogen
11.1.2.5 Market Breakup by Drug Class
11.1.2.6 Market Breakup by Mechanism of Action
11.1.2.7 Market Breakup by Distribution Channel
11.1.2.8 Key Players
11.1.2.9 Market Forecast (2023-2028)
11.2 Europe
11.2.1 Germany

11.2.1.1 Market Drivers
11.2.1.2 Historical and Current Market Trends (2017-2022)
11.2.1.3 Market Breakup by Disease
11.2.1.4 Market Breakup by Pathogen
11.2.1.5 Market Breakup by Drug Class
11.2.1.6 Market Breakup by Mechanism of Action
11.2.1.7 Market Breakup by Distribution Channel
11.2.1.8 Key Players
11.2.1.9 Market Forecast (2023-2028)
11.2.2 France
11.2.2.1 Market Drivers
11.2.2.2 Historical and Current Market Trends (2017-2022)
11.2.2.3 Market Breakup by Disease
11.2.2.4 Market Breakup by Pathogen
11.2.2.5 Market Breakup by Drug Class
11.2.2.6 Market Breakup by Mechanism of Action
11.2.2.7 Market Breakup by Distribution Channel
11.2.2.8 Key Players
11.2.2.9 Market Forecast (2023-2028)
11.2.3 United Kingdom
11.2.3.1 Market Drivers
11.2.3.2 Historical and Current Market Trends (2017-2022)
11.2.3.3 Market Breakup by Disease
11.2.3.4 Market Breakup by Pathogen
11.2.3.5 Market Breakup by Drug Class
11.2.3.6 Market Breakup by Mechanism of Action
11.2.3.7 Market Breakup by Distribution Channel
11.2.3.8 Key Players
11.2.3.9 Market Forecast (2023-2028)
11.2.4 Italy
11.2.4.1 Market Drivers
11.2.4.2 Historical and Current Market Trends (2017-2022)
11.2.4.3 Market Breakup by Disease
11.2.4.4 Market Breakup by Pathogen
11.2.4.5 Market Breakup by Drug Class
11.2.4.6 Market Breakup by Mechanism of Action
11.2.4.7 Market Breakup by Distribution Channel
11.2.4.8 Key Players
11.2.4.9 Market Forecast (2023-2028)
11.2.5 Spain
11.2.5.1 Market Drivers
11.2.5.2 Historical and Current Market Trends (2017-2022)
11.2.5.3 Market Breakup by Disease
11.2.5.4 Market Breakup by Pathogen
11.2.5.5 Market Breakup by Drug Class
11.2.5.6 Market Breakup by Mechanism of Action
11.2.5.7 Market Breakup by Distribution Channel
11.2.5.8 Key Players
11.2.5.9 Market Forecast (2023-2028)
11.2.6 Others
11.2.6.1 Historical and Current Market Trends (2017-2022)
11.2.6.2 Market Forecast (2023-2028)
11.3 Asia Pacific
11.3.1 China

11.3.1.1 Market Drivers
11.3.1.2 Historical and Current Market Trends (2017-2022)
11.3.1.3 Market Breakup by Disease
11.3.1.4 Market Breakup by Pathogen
11.3.1.5 Market Breakup by Drug Class
11.3.1.6 Market Breakup by Mechanism of Action
11.3.1.7 Market Breakup by Distribution Channel
11.3.1.8 Key Players
11.3.1.9 Market Forecast (2023-2028)
11.3.2 Japan
11.3.2.1 Market Drivers
11.3.2.2 Historical and Current Market Trends (2017-2022)
11.3.2.3 Market Breakup by Disease
11.3.2.4 Market Breakup by Pathogen
11.3.2.5 Market Breakup by Drug Class
11.3.2.6 Market Breakup by Mechanism of Action
11.3.2.7 Market Breakup by Distribution Channel
11.3.2.8 Key Players
11.3.2.9 Market Forecast (2023-2028)
11.3.3 India
11.3.3.1 Market Drivers
11.3.3.2 Historical and Current Market Trends (2017-2022)
11.3.3.3 Market Breakup by Disease
11.3.3.4 Market Breakup by Pathogen
11.3.3.5 Market Breakup by Drug Class
11.3.3.6 Market Breakup by Mechanism of Action
11.3.3.7 Market Breakup by Distribution Channel
11.3.3.8 Key Players
11.3.3.9 Market Forecast (2023-2028)
11.3.4 South Korea
11.3.4.1 Market Drivers
11.3.4.2 Historical and Current Market Trends (2017-2022)
11.3.4.3 Market Breakup by Disease
11.3.4.4 Market Breakup by Pathogen
11.3.4.5 Market Breakup by Drug Class
11.3.4.6 Market Breakup by Mechanism of Action
11.3.4.7 Market Breakup by Distribution Channel
11.3.4.8 Key Players
11.3.4.9 Market Forecast (2023-2028)
11.3.5 Australia
11.3.5.1 Market Drivers
11.3.5.2 Historical and Current Market Trends (2017-2022)
11.3.5.3 Market Breakup by Disease
11.3.5.4 Market Breakup by Pathogen
11.3.5.5 Market Breakup by Drug Class
11.3.5.6 Market Breakup by Mechanism of Action
11.3.5.7 Market Breakup by Distribution Channel
11.3.5.8 Key Players
11.3.5.9 Market Forecast (2023-2028)
11.3.6 Indonesia
11.3.6.1 Market Drivers
11.3.6.2 Historical and Current Market Trends (2017-2022)
11.3.6.3 Market Breakup by Disease
11.3.6.4 Market Breakup by Pathogen
11.3.6.5 Market Breakup by Drug Class
11.3.6.6 Market Breakup by Mechanism of Action
11.3.6.7 Market Breakup by Distribution Channel
11.3.6.8 Key Players
11.3.6.9 Market Forecast (2023-2028)
11.3.7 Others
11.3.7.1 Historical and Current Market Trends (2017-2022)
11.3.7.2 Market Forecast (2023-2028)
11.4 Latin America
11.4.1 Brazil

11.4.1.1 Market Drivers
11.4.1.2 Historical and Current Market Trends (2017-2022)
11.4.1.3 Market Breakup by Disease
11.4.1.4 Market Breakup by Pathogen
11.4.1.5 Market Breakup by Drug Class
11.4.1.6 Market Breakup by Mechanism of Action
11.4.1.7 Market Breakup by Distribution Channel
11.4.1.8 Key Players
11.4.1.9 Market Forecast (2023-2028)
11.4.2 Mexico
11.4.2.1 Market Drivers
11.4.2.2 Historical and Current Market Trends (2017-2022)
11.4.2.3 Market Breakup by Disease
11.4.2.4 Market Breakup by Pathogen
11.4.2.5 Market Breakup by Drug Class
11.4.2.6 Market Breakup by Mechanism of Action
11.4.2.7 Market Breakup by Distribution Channel
11.4.2.8 Key Players
11.4.2.9 Market Forecast (2023-2028)
11.5.3 Others
11.5.3.1 Historical and Current Market Trends (2017-2022)
11.5.3.2 Market Forecast (2023-2028)
11.6 Middle East and Africa
11.6.1 Market Drivers
11.6.2 Historical and Current Market Trends (2017-2022)
11.6.3 Market Breakup by Disease
11.6.4 Market Breakup by Pathogen
11.6.5 Market Breakup by Drug Class
11.6.6 Market Breakup by Mechanism of Action
11.6.7 Market Breakup by Distribution Channel
11.6.8 Market Breakup by Country
11.6.9 Key Players
11.6.10 Market Forecast (2023-2028)
11.7 Attractive Investment Proposition by Region

12 Global Antibiotic Resistance Market – Competitive Landscape
12.1 Overview
12.2 Market Structure
12.3 Market Share by Key Players
12.4 Market Player Positioning
12.5 Top Winning Strategies
12.6 Competitive Dashboard
12.7 Company Evaluation Quadrant

13 Profiles of Key Player
13.1 Aridis Pharmaceuticals Inc.

13.1.1 Business Overview
13.1.2 Products Offered
13.1.3 Business Strategies
13.1.4 SWOT Analysis
13.1.5 Major News and Events
13.2 Basilea Pharmaceutica International Ltd
13.2.1 Business Overview
13.2.2 Products Offered
13.2.3 Business Strategies
13.2.4 SWOT Analysis
13.2.5 Major News and Events
13.3 Bioversys AG
13.3.1 Business Overview
13.3.2 Products Offered
13.3.3 Business Strategies
13.3.4 SWOT Analysis
13.3.5 Major News and Events
13.4 Entasis Therapeutics Holdings Inc. (Innoviva Inc)
13.4.1 Business Overview
13.4.2 Products Offered
13.4.3 Business Strategies
13.4.4 SWOT Analysis
13.4.5 Major News and Events
13.5 Melinta Therapeutics LLC
13.5.1 Business Overview
13.5.2 Products Offered
13.5.3 Business Strategies
13.5.4 SWOT Analysis
13.5.5 Major News and Events
13.6 Nabriva Therapeutics plc
13.6.1 Business Overview
13.6.2 Products Offered
13.6.3 Business Strategies
13.6.4 SWOT Analysis
13.6.5 Major News and Events
13.7 Paratek Pharmaceuticals Inc. 
13.7.1 Business Overview
13.7.2 Products Offered
13.7.3 Business Strategies
13.7.4 SWOT Analysis
13.7.5 Major News and Events
13.8 Quretech Bio AB
13.8.1 Business Overview
13.8.2 Products Offered
13.8.3 Business Strategies
13.8.4 SWOT Analysis
13.8.5 Major News and Events
13.9 Seres Therapeutics Inc.
13.9.1 Business Overview
13.9.2 Products Offered
13.9.3 Business Strategies
13.9.4 SWOT Analysis
13.9.5 Major News and Events

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

14 Global Antibiotic Resistance Market - Industry Analysis
14.1 Drivers, Restraints, and Opportunities

14.1.1    Overview
14.1.2    Drivers
14.1.3    Restraints
14.1.4    Opportunities
14.1.5    Impact Analysis
14.2   Porters Five Forces Analysis
14.2.1    Overview
14.2.2    Bargaining Power of Buyers
14.2.3    Bargaining Power of Suppliers
14.2.4    Degree of Competition
14.2.5    Threat of New Entrants
13.2.6    Threat of Substitutes
14.3 Value Chain Analysis

15 Strategic Recommendations

16 Appendix

Antibiotic Resistance Market Report by Disease (CUTI (Complicated Urinary Tract Infections), CDI (Clostridioides Difficile Infection), ABSSSI (Acute Bacterial Skin and Skin Structure Infections), HABP (Hospital-Acquired Bacterial Pneumonia), CABP (Community-Acquired Pneumonia), CIAI (Complicated Intra-Abdominal Infection), BSI (Bloodstream Infection)), Pathogen (E. Coli, K. Pneumoniae, P. Aeruginosa, S. Aureus, A. Baumannii, S. Pneumoniae, H. Influenzae, C. Difficile, E. Faecium), Drug Class (Oxazolidinones, Lipoglycopeptides, Tetracyclines, Combination Therapies, Cephalosporins, and Others), Mechanism of Action (Protein Synthesis Inhibitors, Cell Wall Synthesis Inhibitors, RNA Synthesis Inhibitors, DNA Synthesis Inhibitors, and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and Region 2023-2028
Purchase options




Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Get in Touch With Us
UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-713-2163

Email: sales@imarcgroup.com

Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Greenfish S.A.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More
KRISHAK BHARTI CO-OP LTD

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More
Stax

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More